Eisai collaborates with University of Tokyo for protein degradation drug discovery
Drug Discovery | News | 0 Comment | 13 Oct, 2020
The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...Read more
Antengene establishes new drug discovery centre in Shanghai
Drug Discovery | News | 0 Comment | 13 Oct, 2020
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...Read more
Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis
Drug Discovery | News | 0 Comment | 09 Oct, 2020
Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...Read more
Standigm releases AI-based target identification platform for drug discovery
Drug Discovery | News | 0 Comment | 01 Oct, 2020
South Korea based Standigm Inc., an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, ...Read more
Standigm partners with Excelra to enhance AI-driven drug discovery process
Drug Discovery | News | 0 Comment | 15 Sep, 2020
Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...Read more
Eisai takes Counter-Measures to tackle COVID-19 spread in Africa
Drug Discovery | News | 0 Comment | 10 Jun, 2020
Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...Read more
India's Sun Pharma to start nafamostat mesylate trial for COVID-19
Drug Discovery | Analysis | 2 Comment | 03 Jun, 2020
India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical tri...Read more
Roche’s Tecentriq approved for extensive-stage small cell lung cancer
Drug Discovery | News | 0 Comment | 19 May, 2020
Roche, a global leading provider of pharmaceuticals and cancer treatments, today announced that the Health Sciences Auth...Read more
Exyte and Univercells combine forces for rapid deployment of COVID-19 vaccine
Drug Discovery | News | 0 Comment | 14 May, 2020
Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a prov...Read more
Astellas, Insilico Medicine bank on AI for drug discovery
Drug Discovery | News | 0 Comment | 04 May, 2020
Hong Kong based Insilico Medicine has announced that it has entered into a research collaboration agreement with Ja...Read more
Senhwa Biosciences, NIH to co-develop COVID-19 drug
Drug Discovery | News | 0 Comment | 27 Apr, 2020
Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...Read more
Esperion & Otsuka to develop treatment for hypercholesterolemia
Drug Discovery | News | 0 Comment | 23 Apr, 2020
US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...Read more
Insilico collaborates with BI for discovering therapeutic targets
Drug Discovery | News | 0 Comment | 23 Apr, 2020
Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...Read more
Combined treatment from existing drugs might combat COVID-19
Drug Discovery | News | 0 Comment | 17 Apr, 2020
There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...Read more
Fujifilm accelerates favipiravir production for COVID-19 treatment
Drug Discovery | News | 0 Comment | 16 Apr, 2020
Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...Read more
Australia’s CDD Cures Crohn’s Disease
Drug Discovery | News | 1 Comment | 15 Apr, 2020
The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...Read more
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Drug Discovery | News | 0 Comment | 10 Apr, 2020
Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...Read more
Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy
Drug Discovery | News | 0 Comment | 10 Apr, 2020
Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...Read more